Use of Severity Grades to Characterize Histopathologic Changes

Author:

Schafer Kenneth A.1,Eighmy John2,Fikes James D.3,Halpern Wendy G.4,Hukkanen Renee R.5,Long Gerald G.6,Meseck Emily K.7,Patrick Daniel J.8,Thibodeau Michael S.9,Wood Charles E.10,Francke Sabine11

Affiliation:

1. Vet Path Services, Inc., Mason, Ohio, USA

2. Covance Laboratories, Inc., Madison, Wisconsin, USA

3. Biogen, Cambridge, Massachusettes, USA

4. Genentech, South San Francisco, California, USA

5. Eisai, Inc., Andover, Masschusettes, USA

6. Experimental Pathology Laboratories, Inc., Sterling, Virginia, USA

7. Novartis Institutes for Biomedical Research, East Hanover, New Jersey, USA

8. MPI Research, Mattawan, Michigan, USA

9. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA

10. U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA

11. Food and Drug Administration, College Park, Maryland, USA

Abstract

The severity grade is an important component of a histopathologic diagnosis in a nonclinical toxicity study that helps distinguish treatment-related effects from background findings and aids in determining adverse dose levels during hazard characterization. Severity grades should be assigned based only on the extent (i.e., amount and complexity) of the morphologic change in the examined tissue section(s) and be clearly defined in the pathology report for critical lesions impacting study interpretation. However, the level of detail provided and criteria by which severity grades are assigned can vary, which can lead to inappropriate comparisons and confusion when evaluating pathology results. To help address this issue, a Working Group of the Society of Toxicologic Pathology’s Scientific and Regulatory Policy Committee was formed to provide a “points to consider” article on the assignment and application of pathology severity grades. Overall, the Working Group supports greater transparency and consistency in the reporting of grading scales and provides recommendations to improve selection of diagnoses requiring more detailed severity criteria. This information should enhance the overall understanding by toxicologic pathologists, toxicologists, and regulatory reviewers of pathology findings and thereby improve effective communication in regulatory submissions.

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3